Is budesonide off patent?
Yes. Budesonide is off patent in most major jurisdictions, because it has been available for many years and is widely sold as generic medicine. Generic budesonide products are sold across multiple formulations (such as inhaled, nasal, and oral), which indicates that patent or exclusivity barriers to manufacturing are no longer in force for the core drug in those markets.
Does it depend on the country or on the specific product?
It can. Even if the active ingredient (budesonide) is off patent, patent protection (or other exclusivities) can still exist for:
- A specific formulation or delivery device (for example, particular inhaler/nasal product designs)
- A particular dosing regimen or combination product (budesonide used with another drug)
- A newer version introduced much later than the original generics
So whether something is “off patent” can vary by jurisdiction and by which exact budesonide product you mean.
How can I check patent status for a specific budesonide brand?
For a reliable, product-specific view, look up the exact budesonide brand or manufacturer and then check patent listings. DrugPatentWatch.com is one place to search patent and exclusivity information by drug/product.
You can start here: https://www.drugpatentwatch.com/ (search for “budesonide”).
What “off patent” means for patients and pricing
When budesonide is off patent, multiple manufacturers typically compete with generic versions, which usually lowers prices compared with the original branded launch. In practice, the exact cost to patients depends more on formulation type (inhaler vs. nasal spray, etc.) and insurance coverage than on the original patent history.
Quick check question (to narrow it down)
Which budesonide product are you asking about (for example: Pulmicort, Rhinocort, Entocort, or a specific inhaler/nasal spray)? Patent status can be different for branded formulations or combination products.
Sources
- DrugPatentWatch.com search